Literature DB >> 2664999

Inoculum effect.

I Brook1.   

Abstract

The inoculum effect (IE) is a laboratory phenomenon that is described as a significant increase in the minimal inhibitory concentration of an antibiotic when the number of organisms inoculated is increased. The IE generally occurs with beta-lactam antibiotics in relation to beta-lactamase-producing bacteria. An IE occurs with the first- and second-generation cephalosporins against Staphylococcus aureus and less often with the quinolones, beta-lactam-resistant penicillins, cefoxitin, and aminoglycosides. An IE occurs with the penicillins against the Enterobacteriaceae and Pseudomonas species, and a variable IE occurs with cephalosporins; however, no IE occurs with aminoglycosides, quinolones, imipenem, and chloramphenicol against these organisms. An IE occurs with beta-lactam antibiotics against Haemophilus influenzae and with the penicillins and the cephalosporins against penicillinase-producing Neisseria gonorrhoeae and Branhamella catarrhalis. An IE occurs with the penicillins and cephalosporins against the Bacteroides fragilis group; no IE occurs with cefoxitin and imipenem. Although certain antibiotics exhibit an IE, they are still capable of eradicating infections when administered appropriately. Thus, the clinical significance of this laboratory phenomenon has yet to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664999     DOI: 10.1093/clinids/11.3.361

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  93 in total

Review 1.  Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.

Authors:  A C Cremieux; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals.

Authors:  Sarah Schmidt Grant; Benjamin B Kaufmann; Nikhilesh S Chand; Nathan Haseley; Deborah T Hung
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

Review 3.  Shelter in a Swarm.

Authors:  Rasika M Harshey; Jonathan D Partridge
Journal:  J Mol Biol       Date:  2015-08-12       Impact factor: 5.469

4.  Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations.

Authors:  E J Goldstein; D M Citron; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

5.  A combination of sbmA and tolC mutations in Escherichia coli K-12 Tn10-carrying strains results in hypersusceptibility to tetracycline.

Authors:  Ricardo E de Cristóbal; Paula A Vincent; Raúl A Salomón
Journal:  J Bacteriol       Date:  2007-12-14       Impact factor: 3.490

6.  Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus.

Authors:  D J Livorsi; E Crispell; S W Satola; E M Burd; R Jerris; Y F Wang; M M Farley
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

Review 7.  Impact of the fluoroquinolones on gastrointestinal flora.

Authors:  V Korten; B E Murray
Journal:  Drugs       Date:  1993       Impact factor: 9.546

8.  Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.

Authors:  A Gehrt; J Peter; P A Pizzo; T J Walsh
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

Review 9.  Pharmacokinetics and pharmacodynamics of antibacterial agents.

Authors:  Matthew E Levison; Julie H Levison
Journal:  Infect Dis Clin North Am       Date:  2009-12       Impact factor: 5.982

10.  Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa.

Authors:  Jürgen B Bulitta; Neang S Ly; Jenny C Yang; Alan Forrest; William J Jusko; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.